Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease

Eren F., Kurt R., Ermis F., Atuğ Ö., Imeryuz N., Yılmaz Y.

Clinical Biochemistry, cilt.45, ss.655-658, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1016/j.clinbiochem.2012.03.019
  • Dergi Adı: Clinical Biochemistry
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.655-658
  • Anahtar Kelimeler: Fibroblast growth factor 19, Nonalcoholic fatty liver disease, Hepatocyte ballooning, Enzyme-linked immunosorbent assay, INSULIN-RESISTANCE, METABOLIC SYNDROME, FGF19, STEATOHEPATITIS, MICE
  • Marmara Üniversitesi Adresli: Evet